Severe fever with thrombocytopenia syndrome phlebovirus (SFTSV), listed in the most dangerous pathogens by the World Health Organization, has 12–30% fatality rates with a characteristic thrombocytopenia syndrome. With a majority of clinically diagnosed SFTSV patients older than ~50 years of age, age is a critical risk factor for SFTSV morbidity and mortality. Here, we report an age-dependent ferret model of SFTSV infection and pathogenesis that fully recapitulates the clinical manifestations of human infections. Whereas young adult ferrets (≤2 years of age) did not show any clinical symptoms and mortality, SFTSV-infected aged ferrets (≥4 years of age) demonstrated severe thrombocytopenia, reduced white blood cell counts and high fever with 93% mortality rate. Moreover, a significantly higher viral load was observed in aged ferrets. Transcriptome analysis of SFTSV-infected young ferrets revealed strong interferon-mediated anti-viral signalling, whereas inflammatory immune responses were markedly upregulated and persisted in aged ferrets. Thus, this immunocompetent age-dependent ferret model should be useful for anti-SFTSV therapy and vaccine development.
In 2009, an emerging infectious disease that caused severe fever, thrombocytopenia and leukocytopenia with a high fatality rate was first reported in China1. The disease was named severe fever with thrombocytopenia syndrome (SFTS) and its causative agent, the SFTS phlebovirus (SFTSV) was identified in China in 2010 (refs 1,2,3,4). Since then, the number of SFTS cases has rapidly increased in China, South Korea and Japan5,6,7. Although the average case fatality rate varies between different regions, the mean mortality rates of SFTS cases have remained relatively high in Japan (27%), South Korea (23.3%) and China (5.3%)7,8,9,10,11,12. Thus, the World Health Organization ranked SFTSV among the nine most dangerous pathogens that will most likely cause wide epidemics in the near future, requiring urgent attention13. SFTSV belongs to the genus Phlebovirus of the family Phenuiviridae (the order Bunyavirales)2 along with other tick-borne Phleboviruses, including Heartland virus and Lone star virus that have been isolated from humans and ticks in the United States14,15.
Although there are growing concerns regarding the increasing SFTSV infection rates, limited information regarding its pathogenesis is currently available. This is owing to the lack of an animal model that displays a similar clinical manifestation pattern and high mortality in response to this virus. Previously, type I interferon (IFN)-deficient mice16, newborn mice17 and mitomycin-treated mice18 have all been used in attempts to understand the pathogenesis of SFTSV infection. However, both IFN-deficient and mitomycin-treated mice are immunocompromised and cannot utilize the normal immune response against virus infection. Furthermore, newborn animal models, including mice and hamsters17, are also not ideal for studying human SFTSV pathogenesis as the majority of human patients with severe symptoms and increased mortality were more than 50 years of age19. In addition, in rhesus macaques, SFTSV does not cause severe symptoms or death but causes fever, thrombocytopenia and leukocytopenia, suggesting that rhesus monkey infection resembles only a mild form of SFTSV infection in humans20. Thus, the development of an animal model that mimics severe/fatal human SFTS is crucial for understanding the pathogenesis of SFTSV and host immune response to its infection to facilitate the development of medical countermeasures, including vaccines and therapeutics. In this study, we examined the susceptibilities of four different inbred mouse strains and an outbred ferret model (Mustela putorius furo) to SFTSV infection, with separate studies for young adult and aged animals, to establish an animal model of this disease.
Experimental SFTSV infection in young adult and aged mice and ferrets
To identify an animal model that mimics the clinical manifestation and profile of SFTSV human infection, we examined various mouse strains (BALB/c, C3H, C57BL/6 and FVB) and ferrets following infection with the SFTSV CB1/2014 strain21. Groups of 8-week-old mice (young adult mice, n = 5) and 20–24-month-old ferrets (young adult ferrets, n = 5) were intramuscularly (i.m.) inoculated with 0.1 and 1 ml infection volume of stock virus (107.6 TCID50 (50% tissue culture infective dose) of SFTSV CB1/2014), respectively, which was the maximal cell culture dose of this virus. Survival and body weight were recorded for 16 days after inoculation. Neither mice nor young adult ferrets exhibited any mortality over the course of the experiment even when inoculated with the highest titre of SFTSV CB1/2014 (Supplementary Fig. 1a,c). Furthermore, SFTSV-inoculated mice exhibited a 10–25% increase in mean body weight at 6–10 days post-infection (dpi) (Supplementary Fig. 1b). By contrast, there was a 4–5% decrease in the mean body weight of inoculated ferrets at 4–6 dpi with slightly increased body temperatures (1.3 °C) and a recovery of their original body weight by 8 dpi (Supplementary Fig. 1d,e). These results demonstrate that young adult mice and ferret models do not exhibit severe clinical signs of SFTS, and hence may not be representative models for fatal SFTSV infection in humans.
Based on reported clinical symptoms and mortality rates, human patients over 50 years of age exhibited considerably severe SFTSV infection22. Thus, we hypothesized that aged animals might display symptoms reflective of human infection with SFTSV. We administered the SFTSV CB1/2014 strain via an i.m. injection into aged mice of each strain (≥20 months, BALB/c, C3H, C57BL/6 and FVB; n = 5) and into aged ferrets (≥4 years of age, n = 5) and then compared the clinical manifestations with those of young adult mice and ferrets, respectively. All inoculated mice survived the SFTSV infection, although they showed a slight weight loss at 2–6 dpi before it recovered at 8–16 dpi (Supplementary Fig. 2a,b). By marked contrast, 4 out of 5 aged ferrets (80%) exhibited decreased body weight starting at 2 dpi (Supplementary Fig. 2d) and eventually succumbed to infection by 8 dpi (Supplementary Fig. 2c). Moreover, body temperature of those that succumbed increased by 2.5 °C at 2–6 dpi before eventually dropping down below the normal range. Only one aged ferret returned to normal temperature at 8 dpi, recovered body weight at 12 dpi and ultimately survived (Supplementary Fig. 2c–e). Collectively, these results demonstrate that, although SFTSV infection has limited pathogenic effects on young or aged mice, SFTSV-infected aged ferrets exhibit severe clinical symptoms and a high mortality rate. Thus, we utilized ferrets as an animal model to evaluate the pathogenesis and clinical manifestation of SFTSV infection in an age-dependent manner.
Pathogenesis and clinical manifestation of SFTSV infection in ferrets
To compare the pathogenesis of SFTSV in young adult and aged ferrets, groups of 2-year-old young adult ferrets and 4-year-old aged ferrets were inoculated with 107.6 TCID50 per ml of the SFTSV CB1/2014 strain via an i.m. injection, and body weight and survival were monitored for 16 days. Although most natural infections are caused by tick bites (subdermal), we chose the i.m. route for virus administration, which showed similar results to subcutaneous delivery. As demonstrated in Fig. 1, no mortality was observed in young adult ferrets for 16 days (Fig. 1a) and they showed only a 5% decrease in body weight at 6 dpi (Fig. 1b) with a mild increase in body temperature (Fig. 1c). However, all aged ferret groups showed severe clinical symptoms with high body temperatures and weight loss beginning at 2 dpi and all aged ferrets succumbed by 8 dpi (Fig. 1).
As thrombocytopenia is one of its major clinical symptoms, we collected blood from SFTSV CB1/2014-infected young adult and aged ferrets and compared their homeostasis factors. Our results showed that the mean platelet count of SFTSV-infected young adult ferrets was normal, although it fell to baseline at 6 dpi and returned to the normal range (171.7–1,280.6 × 103 per µl)23,24 at 8 dpi (Fig. 2a). By contrast, SFTSV-infected aged ferrets exhibited more rapid severe thrombocytopenia with a 235 × 103 per µl mean platelet count at 2 dpi than young adult ferrets (400 × 103 per µl mean platelet count) (P < 0.0001), and their platelet numbers continuously decreased to below the normal range from 6 dpi (P < 0.0001) until death (Fig. 2b). We also assessed the number of white blood cells (WBCs), red blood cells and haemoglobin in SFTSV-infected young adult and aged ferrets. The mean WBC counts of SFTSV-infected young adult ferrets decreased until 6 dpi and then recovered by 8 dpi, whereas a gradual decrease in WBC counts of SFTSV-infected aged ferrets continued until death (Fig. 2c,d). In addition, the mean numbers of red blood cells and the levels of haemoglobin of SFTSV-infected young adult and aged ferrets were still within their normal ranges3,24 (Supplementary Fig. 3).
Similar to studies of SFTSV-infected humans25,26,27, blood biochemical analysis of infected ferrets showed elevated levels of aspartate aminotransferase (AST; also known as serum glutamic oxaloacetic transaminase) and alanine aminotransferase (ALT; also known as serum glutamic-pyruvic transaminase). The AST concentration of the SFTSV-infected young adult ferret group increased by about twofold at 4 dpi and decreased thereafter (Fig. 3a), but their mean AST level (117 U l−1) was still within the normal range of 40.1–142.7 U l−1 (ref. 24). However, SFTSV-infected aged ferrets showed a gradual increase in the AST concentration until death, and the peak mean concentration was higher than 208 U l−1 (Fig. 3b). Although the ALT concentration (normal range: 49–242.8 U l−1)24 showed a similar pattern to AST in both ferret groups, the ALT concentration of SFTSV-infected aged ferrets reached a mean peak that was 1.7-times higher than that of SFTSV-infected young adult ferrets (Fig. 3c,d).
Taken together, the platelet and WBC counts and the AST and ALT concentrations of SFTSV-infected ferrets are important indicators of SFTSV pathogenesis, whereas the mean red blood cell counts and haemoglobin concentration do not seem to be critical readouts.
Viral distribution and replication in young adult and aged ferrets
Following infection in humans, SFTSV has been detected in multiple organs, indicating a systemic infection25,26. To identify similarity of SFTSV infection between ferrets and humans, the viral load in brain, lung, liver, spleen, kidney, intestine and spinal cord tissues was evaluated in infected ferrets. All organs of aged ferrets and the spleen, liver, kidneys and lungs of young adult ferrets were positive for SFTSV (Fig. 4). The spleen was the most susceptible organ, as it showed the highest viral load in both young adult and aged ferrets. Furthermore, in aged ferrets, the splenic viral load peaked at 6 dpi with 4.1 log10 RNA copies per g, whereas in young adult ferrets, it peaked at 4 dpi with 2.8 log10 RNA copies per g followed by a gradual decrease until 8 dpi (Fig. 4a). Viral load peaked at 4 dpi in the liver (3.9 log10 RNA copies per g) of aged ferrets, then slightly decreased thereafter until death. In young adult ferrets, the viral load peaked in the liver at 6 dpi with 2.7 log10 RNA copies per g and then decreased dramatically at 8 dpi (Fig. 4b), whereas in the kidney, a moderate virus load of 0.98–1.3 log10 RNA copies per g was observed and disappeared by 8 dpi. Even in the aged ferrets, a similar viral load was observed at 2 and 4 dpi in the kidneys before reaching the peak at 6 dpi with 3.1 log10 RNA copies per g (Fig. 4c). Furthermore, virus was also detected in the lungs with an increasing viral load starting at 2–6 dpi in both young adult and aged ferrets. However, a higher load was detected in aged ferrets with a peak of 3.2 log10 RNA copies per g (than only 1.2 log10 RNA copies per g for young adult ferrets) at 4 dpi (Fig. 4d). Furthermore, viral RNA was detected, albeit at relatively low copy numbers (0.5–1.9 log10 RNA copies per g), in the brain, spinal cord and intestine only in the aged ferret group (Fig. 4e–g). In addition, SFTSV was isolated from most tissue specimens taken from aged ferrets, whereas only spleen tissues (2 out of 3) were positive for virus isolation in young adult ferrets (Supplementary Fig. 5).
Next, we assessed the correlation between the viral load in the blood of SFTSV-infected ferrets and disease pathogenesis and progress. Virus was first detected in the serum of both young adult and aged ferrets at 2 dpi (Fig. 4h). In young adult ferrets, 0.75 log10 viral copies per 0.1 ml was detected at 2 dpi and reached a peak of 2.7 log10 viral copies per 0.1 ml at 4 dpi. However, the viral load in sera was significantly decreased at 6 dpi and then was not detected from 8 dpi onwards (Fig. 4h). Although a low mean viral load (0.9 log10 viral copies per 0.1 ml) was detected in aged ferrets at 2 dpi, the viral load increased continuously until the peak reached 4.3 log10 viral copies per 0.1 ml at 6 dpi, before a majority succumbed at 8 dpi (Fig. 4h). This result clearly demonstrates that the viral load in the blood is strongly associated with the mortality of SFTSV-infected ferrets.
To confirm viral replication in the organs of infected ferrets, immunohistochemistry and RNAscope in situ hybridization assays to detect the SFTSV nucleoprotein (NP) and RNA, respectively, were conducted (Fig. 5 and Supplementary Figs. 6 and 7). These tests showed that SFTSV replication was readily detected in the spleen, liver, kidneys, brain, spinal cord and intestines of aged ferrets (Fig. 5 and Supplementary Fig. 7). In agreement with the viral load, SFTSV NP was also detected in the spleen, liver and kidneys (Supplementary Fig. 6a–c) of young adult ferrets. However, SFTSV NP-positive cells were only faintly detected in the brain, spinal cord and intestines (Supplementary Fig. 6d–f) of young adult ferrets. Furthermore, more severe histopathological damages were demonstrated in aged ferrets than in young adult ferrets (Supplementary Fig. 8). These findings clearly demonstrate that SFTSV can infect and replicate in multiple organs and suggest that systemic infection of ferrets occurs in an age-dependent manner.
Transcriptional profile of immune-related genes in peripheral blood mononuclear cells of SFTSV-infected ferrets
To compare global and dynamic gene expression in SFTSV-infected young adult and aged ferrets, RNA sequencing (RNA-seq) analysis was performed on peripheral blood mononuclear cells (PBMCs) from SFTSV-infected young adult and aged ferrets at 2 and 4 dpi. Using the 24,417 annotated genes in the ferret genome database, gene expression was quantified in both ferret groups and compared to that of the phosphate-buffered saline (PBS)-treated ferret control. Differentially expressed genes (DEGs) with a P < 0.05 were identified, as previously described27. The differentially expressed mRNAs in SFTSV-infected young adult and aged ferrets (with ±2-fold changes) are depicted as overlapping circles (Fig. 6a), with the number of differing mRNAs indicated in each area. Briefly, when compared to PBS-treated ferrets, a total of 539 genes were significantly changed in SFTSV-infected ferrets at all time points, regardless of age. Of these, 269 genes were upregulated and 268 genes were downregulated upon infection. The remaining two genes were not consistently expressed across time points. Among the immune-associated DEGs, 2′-5′-oligoadenylate synthetase-like (OASL), which has antiviral activity, was the most significantly upregulated gene followed by the C-X-C motif chemokine 10 (CXCL10), a well-known player in the antiviral response. The expression of these two genes was higher in the aged group than in the young adult group at 4 dpi (54.80 versus 30.51- and 36.22 versus 28.37-fold change, respectively) (Fig. 6a). By contrast, the levels of interleukin-5 (IL-5) receptor-α and IL-20 were significantly downregulated. Expression patterns of the upregulated OASL and CXCL10 genes and the downregulated IL5RA and IL20 genes were confirmed by real-time reverse transcription (RT)–PCRs (Supplementary Fig. 9).
To investigate possible biological interactions of DEGs and identify important functional networks, we imported data sets representing genes with altered expression profiles derived from the RNA-seq analyses into the Ingenuity Pathway Analysis (IPA) tool. The highest activated networks (high z-score) were then identified using IPA. The heat map shows the canonical pathways activated by SFTSV infection in young adult and aged ferrets compared to the PBS control group (Fig. 6b). Notably, many key innate immune response pathways, including RIG-I virus sensing, IFN signalling and IFN regulatory factors (IRFs), were significantly upregulated in all SFTSV-infected groups compared to the PBS control group. Interestingly, there was a decrease in IFN and IRF signalling from 2 to 4 dpi in young adults (z-score: 1.51 versus 1.0 and 1.96 versus 0.0, respectively), whereas the aged group showed an increase (Fig. 6b). Furthermore, many of the signalling pathways (that is, the dendritic cell maturation pathway and the p38 mitogen-activated protein kinase signalling pathway) that were upregulated at 2 dpi were subsequently downregulated at 4 dpi in the young adult ferret group, reflecting their recovery from SFTSV infection.
Given the different clinical outcomes of young adult and aged ferrets upon SFTSV infection, we further investigated the expression of other critical DEGs between two groups (Fig. 6c). Many inflammatory-associated pathways, such as dendritic cell maturation (z-score: 2.79), leukocyte extravasation (z-score: 2.65) and IL-6 signalling (z-score: 1.94), were significantly upregulated in aged ferrets compared to the young adult ferrets, suggesting severe inflammatory responses in older ferrets. By contrast, the apoptosis-associated signalling pathway was downregulated in aged ferrets. Furthermore, higher levels of inflammatory macrophage recruitment factors, such as transforming growth factor-β2 and matrix metalloproteinase 9, were present in aged ferrets than in young adult ferrets, which implied increased inflammatory cell infiltration into sites of infection in aged ferrets (Supplementary Fig. 10).
Despite the increasing incidence of SFTSV human infections and the public health concerns caused by this virus, details regarding the pathogenesis of this virus are largely unknown due to the lack of a proper experimental model. In this study, we demonstrate the age-associated mortality of SFTSV infection using a ferret model. Although the case fatality rates (CFR) in human patients varied from 5.3 to 27% depending on which year and which country reports were from7,9,10,11,12, aged ferrets showed a CFR as high as 93%. The underlying reason for this marked difference might be explained by two factors, the first being that the dose (107.6 TCID50 per ml) of SFTSV introduced into the animal model is probably much higher than that introduced to humans by a tick bite. The second reason may be age. Although SFTSV infection has fatality rates ranging from 5% to as high as 30% in all ages of infected human, it exhibits a drastically increased fatality rate in human patients who are more than 50 years of age7,9,10,11,12. Similarly, no case mortality was observed in young adult ferrets and a high CFR following SFTSV infection was observed in aged ferrets. Thus, the high CFR in this study may be due to a synergistic effect of high inoculum dose and age. The results of haematological analysis clearly recapitulated the clinical manifestation of fatal human disease (Figs. 2 and 3). According to a meta-analysis of human patients with SFTSV infection in China, older and immunocompromised patients had difficulty recovering platelet and WBC counts, which was believed to lead to high mortality19. This finding is well within agreement with our aged ferret experiment. Furthermore, the aged ferrets showed significantly increased AST and ALT concentrations up until death, suggestive of viral hepatitis as was reported in human patients26. These haematology results clearly demonstrate that haemostasis in SFTSV-infected aged ferrets is reflective of that seen in severe-to-fatal human cases of SFTSV infection8. It should be noted that, within the scope of animal model development for SFTSV infection and pathogenesis, we did not determine the specific 50% lethal dosage in ferrets, as ferrets are outbred animals unlike inbred mice and, specially, aged ferrets are quite limited. However, it would be important for future works, such as the evaluation of therapeutic drugs or vaccines.
SFTSV was frequently detected in the serum, spleen, lungs, liver and kidneys both in young adult and in aged ferrets (Fig. 4). In addition, histopathological staining with SFTSV antibody revealed a high viral load especially in the spleen, liver and kidneys in aged ferrets. Although young adult and aged ferrets showed virus replication in most of the peripheral organs (the spleen, liver, kidneys, lungs and blood), only aged ferrets showed viral transcripts in the brain and spinal cord. These results also suggest that the dissemination of SFTSV into the central nervous system might be associated with the death of aged ferrets. However, the dissemination of SFTSV in the brain and spinal cord was not a unique feature of the aged ferrets as the detection of SFTSV in the brain and spinal cord has been previously reported in knockout mouse models and human infection cases16,28,29. Although no central nervous system-related symptoms were observed in the current study, possibly due to the fact that infected ferrets succumbed rapidly, further study will be required to elucidate any association between SFTSV dissemination into the central nervous system and case fatality. It should be noted that, although the virus could be transiently detected in the spleen, liver and kidneys of infected aged mice, the virus copy number was significantly lower than that seen in infected ferrets (Fig. 4 and Supplementary Fig. 4). With this attenuated virus replication, the immune-competent mouse strains did not induce any clinical symptoms and, hence, would not be a useful model for SFTSV-induced diseases in humans.
Many factors differentiate the degree of disease caused by this SFTSV between young adult and aged ferrets. Of these, the immune response seems to be a critical factor for protection from this virus. Transcriptional profile analyses of PBMCs revealed that IFN and IRF signalling pathways were significantly upregulated in SFTSV-infected groups compared to the PBS control group, although higher z-scores were observed in young adult ferrets than in aged ferrets (Fig. 6b). Further analysis demonstrated that many inflammatory-associated pathways were significantly upregulated and persisted in aged ferrets compared to the young adult ferrets. For instance, CCL5 chemokine, which plays an active role in recruiting T cells, eosinophils and basophils into inflammatory sites, was persistently upregulated only in aged ferrets (Fig. 6a and Supplementary Fig. 9e). Thus, this suggests that severe and persistent inflammatory responses are mediated by activated immune-modulating cells in aged ferrets. This correlates with the high viral load in the aged group (Figs. 4 and 6c). Together, these results suggest that the rapid and strong responses of IFN and IRF signalling pathways effectively suppress early virus infection and proliferation, eventually leading to rapid clearance of SFTSV from young adult ferrets. By contrast, aged ferrets exhibit delayed IFN and IRF responses with persistently upregulated inflammatory immune responses, such as the production of chemokines associated with leukocyte extravasation, and a high production of nitric oxide and reactive oxygen species by macrophages (z-score: 1.54), resulting in tissue damage and mortality of SFTSV-infected aged ferrets. Both aged humans and ferrets may have attenuated immune function that is necessary to protect the body against invading antigens. This is thought to be due to decreases in the number of plasma fluid cells and monocytes30,31. Thus, an attenuated immune system seems to underlie the marked replication of viral pathogens, such as SFTSV, in aged populations, consequently causing increased disease severity and eventually leading to death.
Taken together, our data indicate that at least three different factors may be involved in SFTSV-induced mortality: the depletion of platelets and WBCs, delayed innate immune responses and a high viral load in the bloodstream. Furthermore, our results suggest the potential usefulness of ferrets as an animal model for SFTSV pathogenesis and that the ferret model would be suitable for the assessment of many biomedical parameters, such as antiviral drug screening and vaccine efficacy tests.
Virus and cells
SFTSV strain CB1/2014 was isolated from the sera of SFTSV-infected patients who were hospitalized with typical SFTS symptoms at Chungbuk National University Hospital (Cheongju, South Korea)21. For virus propagation, the virus was passaged five times on confluent monolayers of Vero E6 cells (ATCC no. CRL-1586; American Type Culture Collection) in DMEM (Gibco) containing 2% FBS (Gibco) with penicillin (100 U ml−1) and streptomycin (100 μg ml−1; Gibco) placed in a 37 °C incubator supplemented with 5% CO2. Cell culture supernatant was collected at 7 dpi and stored at −80 °C as the working virus stock for animal studies. Viral infectivity titres were determined through an immunostaining assay in which the TCID50 was determined with an in-house-generated monoclonal NP antibody against SFTSV in an immunofluorescence assay.
Mouse infection study
Eight-week-old or aged (≥20 months of age) mice (n = 17 per group) of each strain (BALB/c, C3H, C57BL/6 and FVB) were i.m. inoculated with 106.6 TCID50 per animal of SFTSV CB1/2014 strain (50 µl in the outside of the thigh of both legs). The mice (n = 5 per group) were monitored for body weight and clinical symptoms daily for 16 days. The remaining mice (n = 3 per group) were killed to evaluate the viral copy numbers in tissues at 2, 4, 6 and 8 dpi.
Ferret infection study
Two groups of young adults (20–24 months of age, ≤2 years of age) and aged ferrets (48–50 months of age), ≥4 years of age) were inoculated via the i.m. route with 107.6 TCID50 of the SFTSV CB1/2014 strain (0.5 ml in the outside of the thighs of both legs). Blood was collected from anaesthetized ferrets every other day for various assays and virus titration. To access virus replication of SFTSV-infected ferrets, a single ferret from each group was killed at 2, 4, 6 or 8 dpi, and the brain, lung, liver, spleen, kidney, intestine and spinal cord tissues were collected with individual scissors to avoid the cross-contamination. This study was conducted with three independent trials; hence, a total of 21 ferrets were infected in each group. In this study, two trials (14 ferrets) used female ferrets and one trial was conducted with 7 male ferrets. However, the CFR and haematological parameters were similar between sexes.
Haematological and biochemical assays
Haematological parameters were analysed in EDTA-treated whole blood from infected animals using the Celltac hematology analyzer (MEK-6550J/K, Nihon Kohden). Biochemical parameters of serum from infected animals were determined using Celltac-α (MEK-6550, Nihon Kohden).
Total RNA was extracted using TRIzol reagent (Thermo Fisher Scientific) or the RNeasy kit (Qiagen) and cDNAs were generated by reverse transcription using QuantiTect Reverse Transcription (Qiagen). Viral copy numbers were determined by real-time RT–PCR with an M segment-based SFTSV-specific primer set. The forward primer was SFTSV-M-F: AATTCACATTTGAGGGTAGTT and the reverse primer was SFTSV-M-R: TATCCAAGGAGGATGACAATAAT. Copy numbers were calculated as a ratio with respect to the standard control28, and gene expression of relative fold change was calculated with ΔΔCT methods and normalized to the expression levels of the GAPDH gene. Real-time PCR reactions were performed using a SYBR Green Supermix (Bio-Rad) and a CFX96 Touch Real-Time PCR Detection System (Bio-Rad).
For immunohistochemistry analysis, we collected tissue samples (the brain, lung, liver, spleen, kidney, intestine and spinal cord) at 6 dpi from CB1/2014-infected young adult or aged ferrets. The samples were fixed in 10% neutral-buffered formalin and embedded in paraffin according to the standard procedures. The embedded tissues were sectioned and dried for 3 days at room temperature. To detect the viral antigen by immunohistochemistry, a monoclonal antibody against SFTSV was used as the primary antibody. Antigen was visualized using the biotin-avidin system (Vector Labs). Slides were viewed using the Olympus IX 71 (Olympus) microscope with DP controller software to capture images.
RNAscope in situ hybridization
SFTSV RNA (NP segment) was detected using the NP-specific probe (552071, Advanced Cell Diagnotics) and visualized using the RNAscope 2.5 HD Reagent Kit RED (322360, Advanced Cell Diagnotics). Organ tissue sections were fixed in 10% neutral-buffered formalin and embedded in paraffin, according to the manufacturer’s instructions, followed by counterstaining with haematoxylin (H3401, Vector Laboratories). Sections were imaged using the BZ 9000 all-in-one Fluorescence Microscope from Keyence and analysed using the NIH Image J software.
PBMCs were isolated at 2 and 4 dpi from each group of ferrets (n = 3) by density gradient centrifugation using Ficoll-Paque Plus (GE Healthcare Biosciences) according to the manufacturer’s protocol. Total RNA was extracted from PBMCs of mock PBS control and SFTSV CB1/2014-infected ferrets using the RNeasy Micro Kit (Qiagen) according to the manufacturer’s protocol. RNA quantity was assessed by spectrophotometry using Nanodrop 1000 (Thermo Fisher Scientific).
Analysis of the RNA-seq transcriptome
To evaluate the differential expression of cellular response in PBMCs, RNA-seq was performed. The cDNA libraries were constructed from PBMC RNA samples and was sequenced using an Illumina HiSeq 2500 sequencer, as described previously. One paired-end library with an insert size for each sample of 100 bp was sequenced. Raw reads were assembled using CLC Genomics Workbench (version 11), in which low-quality reads were filtered and the filtered reads were subsequently mapped to a reference genome downloaded from Ensembl (MusPutFur1.0). Data analysis was performed using the two-sided Wald test to calculate false discovery rates (FDR-adjusted P < 0.05) and to identify DEGs. Furthermore, DEGs generated molecular networks according to biological and molecular importance, including canonical pathways, upstream and downstream regulatory analysis through the Ingenuity Knowledge Base. Fisher’s exact test (P > 0.05) and inhibition or activation z-scores were calculated by IPA.
The asterisks indicate significant differences in weight loss, temperature change, blood analysis, viral load and titre between groups and across time points as determined by the two-tailed Mantel–Cox method or two-tailed unpaired t-test. Statistical analyses were performed using GraphPad Prism version 8.00 for Windows (GraphPad Software).
All animal experiments were approved by the Medical Research Institute, a member of the Laboratory Animal Research Center of Chungbuk National University (LARC) (approval number: CBNUA-986-16-01), and were conducted in strict accordance and adherence to relevant policies regarding animal handling as mandated under the Guidelines for Animal Use and Care of the Korea Centers for Disease Control and Prevention. Viruses were handled in an enhanced biosafety level 3 containment laboratory as approved by the Korean Centers for Disease Control and Prevention (KCDC-14-3-07).
Further information on research design is available in the Nature Research Reporting Summary linked to this article.
The data that support the findings of this study are available from the corresponding authors upon request. The RNA-seq data were deposited in the Gene Expression Omnibus (GEO) under the accession number GSE121911.
Wiwanitkit, S. & Wiwanitkit, V. Acute viral hemorrhage disease: a summary on new viruses. J. Acute Dis. 4, 277–279 (2015).
Adams, M. J. et al. Changes to taxonomy and the International Code of Virus Classification and Nomenclature ratified by the International Committee on Taxonomy of Viruses (2017). Arch. Virol. 162, 2505–2538 (2017).
Kim, K.-H. et al. Severe fever with thrombocytopenia syndrome, South Korea, 2012. Emerg. Infect. Dis. 19, 1892–1894 (2013).
Takahashi, T. et al. The first identification and retrospective study of severe fever with thrombocytopenia syndrome in Japan. J. Infect. Dis. 209, 816–827 (2013).
SFTSV Infection in Korea (KCDC, 2016); http://cdc.go.kr/CDC/mobile/notice/CdcKrIntro0201.jsp?menuIds=HOME001-MNU1154-MN&fid=21&q_type=&q_value=&cid=73941&pageNum=1
NIID. Severe fever with thrombocytopenia syndrome (SFTS) in Japan, as of February 2016. IASR 37, 39–40 (2016).
Zhan, J. et al. Current status of severe fever with thrombocytopenia syndrome in China. Virol. Sin. 32, 51–62 (2017).
Li, D. Severe fever with thrombocytopenia syndrome: a newly discovered emerging infectious disease. Clin. Microbiol. Infect. 21, 614–620 (2015).
Baba, M. et al. Establishment of an antiviral assay system and identification of severe fever with thrombocytopenia syndrome virus inhibitors. Antivir. Chem. Chemother. 25, 83–89 (2017).
Disease Web Statistics System (KCDC, 2017); http://www.cdc.go.kr/npt/biz/npp/ist/bass/bassDissStatsMain.do
Epidemiologic and Clinical Characteristics of Severe Fever with Thrombocytopenia Syndrome in the Republic of Korea (KCDC, 2016); http://cdc.go.kr/CDC/together/CdcKrTogether0302.jsp?menuIds=HOME001-MNU1154-MNU0005- MNU0088&fid=51&q_type=title&q_value=SFTS&cid=69842&pageNum=
Caution of SFTS Infection at Outdoor Activity (KCDC, 2018); http://www.cdc.go.kr/npt/biz/npp/portal/nppSumryMain.do?icdCd=D0018&icdgrpCd=04&icdSubgrpCd=
2018 Annual Review of Diseases Prioritized Under the Research and Development Blueprint. WHO Research and Development Blueprint (WHO, 2018).
Pepin, M., Bouloy, M., Bird, B. H., Kemp, A. & Paweska, J. Rift Valley fever virus (Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention. Vet. Res. 41, 61 (2010).
Swei, A. et al. The genome sequence of Lone Star virus, a highly divergent bunyavirus found in the Amblyomma americanum tick. PLoS ONE 8, e62083 (2013).
Liu, Y. et al. The pathogenesis of severe fever with thrombocytopenia syndrome virus infection in alpha/beta interferon knockout mice: insights into the pathologic mechanisms of a new viral hemorrhagic fever. J. Virol. 88, 1781–1786 (2014).
Chen, X.-P. et al. Infection and pathogenesis of Huaiyangshan virus (a novel tick-borne bunyavirus) in laboratory rodents. J. Gen. Virol. 93, 1288–1293 (2012).
Jin, C. et al. Pathogenesis of emerging severe fever with thrombocytopenia syndrome virus in C57/BL6 mouse model. Proc. Natl Acad. Sci. USA 109, 10053–10058 (2012).
Liu, S. et al. Systematic review of severe fever with thrombocytopenia syndrome: virology, epidemiology, and clinical characteristics. Rev. Med. Virol. 24, 90–102 (2014).
Jin, C. et al. SFTS virus infection in nonhuman primates. J. Infect. Dis. 211, 915–925 (2014).
Yun, S.-M. et al. Molecular genomic characterization of tick-and human-derived severe fever with thrombocytopenia syndrome virus isolates from South Korea. PLoS Negl. Trop. Dis. 11, e0005893 (2017).
Sun, J. et al. Factors associated with severe fever with thrombocytopenia syndrome infection and fatal outcome. Sci. Rep. 6, 33175 (2016).
Smith, S. A., Zimmerman, K. & Moore, D. M. Hematology of the domestic ferret (Mustela putorius furo). Vet. Clin. North Am. Exot. Anim. Prac. 18, 1–8 (2015).
Hein, J., Spreyer, F., Sauter-Louis, C. & Hartmann, K. Reference ranges for laboratory parameters in ferrets. Vet. Rec. 171, 218 (2012).
Li, S. et al. Multiple organ involvement in severe fever with thrombocytopenia syndrome: an immunohistochemical finding in a fatal case. Virol. J. 15, 97 (2018).
Hiraki, T. et al. Two autopsy cases of severe fever with thrombocytopenia syndrome (SFTS) in Japan: a pathognomonic histological feature and unique complication of SFTS. Pathol. Int. 64, 569–575 (2014).
Park, S.-J. et al. Dynamic changes in host gene expression associated with H5N8 avian influenza virus infection in mice. Sci. Rep. 5, 16512 (2015).
Shimada, S., Posadas-Herrera, G., Aoki, K., Morita, K. & Hayasaka, D. Therapeutic effect of post-exposure treatment with antiserum on severe fever with thrombocytopenia syndrome (SFTS) in a mouse model of SFTS virus infection. Virology 482, 19–27 (2015).
Kaneko, M. et al. A patient with severe fever with thrombocytopenia syndrome and hemophagocytic lymphohistiocytosis-associated involvement of the central nervous system. J. Infect. Chemother. 24, 292–297 (2018).
Deng, B. et al. Cytokine and chemokine levels in patients with severe fever with thrombocytopenia syndrome virus. PLoS ONE 7, e41365 (2012).
Liu, J. et al. Dynamic changes of laboratory parameters and peripheral blood lymphocyte subsets in severe fever with thrombocytopenia syndrome patients. Int. J. Infect. Dis. 58, 45–51 (2017).
This work was supported by the Korea Health Technology R&D Project, funded by the Ministry of Health & Welfare, Republic of Korea (HI15C2817), National Research Foundation of Korea (NRF-2017K2A9A1A01092932) to Y.K.C., National Institute of Health (AI129496, AI40718 and AI140705) to J.U.J. and the Ministry of Health & Welfare, Republic of Korea (HI15C2888) to M.-S.S. We thank I.-P. Mo and K.-S. Kim (College of Veterinary Medicine, Chungbuk National University) for their kind support in the immunohistochemistry assay and the haematoxylin and eosin histopathological study.
The authors declare no competing interests.
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Park, SJ., Kim, YI., Park, A. et al. Ferret animal model of severe fever with thrombocytopenia syndrome phlebovirus for human lethal infection and pathogenesis. Nat Microbiol 4, 438–446 (2019). https://doi.org/10.1038/s41564-018-0317-1
This article is cited by
Severe fever with thrombocytopenia syndrome virus replicates in brain tissues and damages neurons in newborn mice
BMC Microbiology (2022)
Clinical Proteomics (2022)
Nature Communications (2022)
A longitudinal sampling study of transcriptomic and epigenetic profiles in patients with thrombocytopenia syndrome
Nature Communications (2021)
Severe fever with thrombocytopenia syndrome virus: emerging novel phlebovirus and their control strategy
Experimental & Molecular Medicine (2021)